French biotech company Abivax said new clinical trial data supports the safety and effectiveness of its experimental ulcerative colitis treatment.
Abivax shares jump 36% as new trial data support ulcerative colitis drug obefazimod
Political Leaning Analysis
Score: 0.00 •
Center / Neutral
Left
Center
Right
Story Timeline
Tue 12:59 - Euronews
Abivax shares jump 36% as new trial data support ulcerative colitis drug obefazimod